Hepatitis C

The European Commission has approved Tecentriq ( Atezolizumab ) in combination with Avastin ( Bevacizumab ) for the treatment of...


The nucleoside-modified messenger RNA in COVID-19 mRNA vaccine BNT162b2 is formulated in lipid nanoparticles, which enable delivery of the RNA...



The use of convalescent plasma is not new; it was used for severe acute respiratory syndrome ( SARS ), pandemic...


Opdivo ( Nivolumab ) 3 mg/kg plus Yervoy ( Ipilimumab ) 1 mg/kg ( injections for intravenous use ) was...


The FDA ( U.S. Food and Drug Administration ) has approved Tecentriq ( Atezolizumab ) in combination with Avastin (...


Whether statin type influences hepatocellular carcinoma ( HCC ) incidence or mortality in chronic hepatitis B or C virus infection...


The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated...


The FDA ( U.S. Food and Drug Administration ) has expanded the approval of Mavyret ( Glecaprevir and Pibrentasvir )...


Sorafenib ( Nexavar ) is approved as first-line therapy for patients with advanced hepatocellular carcinoma ( HCC ), but there...


Results from the phase III IMbrave150 study evaluating Atezolizumab ( Tecentriq ) in combination with Bevacizumab ( Avastin ) were...


Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show an alarmingly...


The FDA ( U.S. Food and Drug Administration ) has approved Dovato ( Dolutegravir and Lamivudine ), as a complete...


In the REACH-2 trial, Ramucirumab ( Cyramza ) has shown a statistically significant benefit in the primary endpoint of overall...


Week 48 results from phase III TANGO study were announced. The TANGO study was conducted to assess whether adults living...


The FDA ( U.S. Food and Drug Administration ) has approved Biktarvy ( Bictegravir 50mg / Emtricitabine 200mg / Tenofovir...



The FDA ( U.S. Food and Drug Administration ) has approved Keytruda ( Pembrolizumab ), an anti-PD-1 therapy, in combination...


The European Commission has approved Delstrigo and Pifeltro for the treatment of HIV-1 infection. Delstrigo is a new once-daily fixed-dose...


Data are sparse on treatment of chronic hepatitis C virus ( HCV ) in cancer patients. Researchers have evaluated the efficacy...